Trials / Recruiting
RecruitingNCT01745237
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 27,000 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.
Detailed description
In patients with sarcoidosis, cardiac death is a leading cause of mortality which may represent unrecognized cardiac involvement. Cardiovascular magnetic resonance (CMR) can detect cardiac involvement including minute amounts of myocardial damage. Therefore, the objective of this study was to determine the usefulness of CMR and compare it with standard clinical evaluation for cardiac involvement. Patients with documented extracardiac sarcoidosis or clinically suspected cardiac sarcoidosis will be enrolled.
Conditions
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2032-06-01
- Completion
- 2032-06-01
- First posted
- 2012-12-10
- Last updated
- 2025-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01745237. Inclusion in this directory is not an endorsement.